Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04760847 · ClinicalTrials.gov registry record · NA
Intermittent Fasting for Pancreatitis
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Not yet
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT04760847: Clinical Trial NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT04760847 is a NA study that has not yet begun recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04760847, a NA study, has not yet begun recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.
Primary Outcome
Pancreas related Quality of Life Index (PANQALI) is pancreas related quality of life index scale from 0 (lowest or better disease activity) to 90 (highest or worse disease activity)
Interventions
- OTHER Intermittent Fasting
- OTHER No intermittent fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2026-03 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What is known before NCT04760847 opens enrollment
NCT04760847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Intermittent Fasting is the first listed.
NCT04760847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04760847 about?
NCT04760847 is a clinical study titled "Intermittent Fasting for Pancreatitis". The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.
What is the current status of trial NCT04760847?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2026-03. Estimated completion is 2026-04-01.
What interventions are being tested in trial NCT04760847?
The interventions under investigation include: Intermittent Fasting (OTHER), No intermittent fasting (OTHER).
Who is sponsoring clinical trial NCT04760847?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04760847's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia